NEUROBO PHARMACEUTICALS INC (NRBO)       15.52  -0.02 (-0.13%)

15.52  -0.02 (-0.13%)

US64132R2067 - Common Stock

NEUROBO PHARMACEUTICALS INC15.52

NASDAQ:NRBO (9/26/2022, 9:46:58 AM)-0.02 (-0.13%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 08-15 2022-08-15 Earnings (Next) 11-14 2022-11-14
Ins Owners 20.7% Inst Owners 137.83%
Market Cap 13.79M Shares 888.73K
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 82.86
IPO 08-05 2016-08-05

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NRBO Daily chart

Company Profile

Neurobo Pharmaceuticals Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Boston, Massachusetts and currently employs 5 full-time employees. The company went IPO on 2016-08-05. NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies. The firm is engaged in providing therapeutic programs designed to impact a range of indications in coronavirus, neurodegenerative and cardiometabolic disease. Its products include ANA001, Niclosamide, NB-01 and NB-02. The ANA001 is an oral niclosamide formulation and is being developed as a treatment for patients with moderate coronavirus disease. Niclosamide is a potential oral antiviral and anti-inflammatory agent and being studied in a 60-subject Phase II clinical trial conducted in the United States. NB-01 primarily focused on the development of a treatment for painful diabetic neuropathy (PDN). NB-02 has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid beta plaque deposition.

Company Info

NEUROBO PHARMACEUTICALS INC

200 Berkeley St., Fl 19

Boston MASSACHUSETTS 02116

P: 18577029600.0

CEO: Richard Kang

Employees: 5

Website: https://www.neurobopharma.com/

NRBO News

News Image5 days ago - ChartmillWhat's going on in today's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

News Image5 days ago - ChartmillWednesday's session: gap up and gap down stocks

Let's have a look at the gap up and gap down stocks in today's session.

News Image5 days ago - ChartmillWednesday's pre-market session: top gainers and losers

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

News Image6 days ago - ChartmillTuesday's after hours session: top gainers and losers

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

News Image6 days ago - ChartmillTuesday's session: top gainers and losers

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.

News Image6 days ago - ChartmillTuesday's session: top gainers and losers

Let's have a look at the top gainers and losers in the middle of the day of today's session.

NRBO Twits

Here you can normally see the latest stock twits on NRBO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example